New Hampshire 2026 Session Status: Introduced 9 R cosponsors

SB 477 — relative to increasing transparency in the 340B Drug Pricing Program.

Last action — Refer to Interim Study, MA, VV; 03/05/2026; SJ 5

  1. 1
    Introduced
  2. 2
    In Committee
  3. 3
    Passed Senate
  4. 4
    Passed House
  5. 5
    To Executive
  6. 6
    Enacted

This bill has been introduced in the Senate. Introduced November 21, 2025. It must pass committee before a floor vote.

Next likely step: a committee referral and hearing.

Odds of enactment

Low chance

Based on the sponsor, cosponsors, and committee posture, this bill has a low chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Not enough signal yet

Not enough signal yet to read this bill's trajectory — we surface a likelihood only once there's real movement (stage, sponsorship, committee, or votes) to point to.

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

Summary

relative to increasing transparency in the 340B Drug Pricing Program.

Bill Text

Action History

  1. Refer to Interim Study, MA, VV; 03/05/2026; SJ 5

  2. Committee Report: Referred to Interim Study, 03/05/2026, Vote 5-0; SC 8

  3. Special Order to the Next Session, Without Objection, MA; 02/19/2026; SJ 4

  4. SB 477 was Removed from the Consent Calendar; 02/19/2026; SJ 4

  5. Committee Report: Referred to Interim Study, 02/19/2026; Vote 5-0; CC; SC 6

  6. Hearing: 01/21/2026, Room 100, SH, 01:30 pm; SC 2

  7. Introduced 01/07/2026 and Referred to Health and Human Services; SJ 1

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 9 co-sponsors · 405 not signed on

Sponsors (1)

Co-sponsors (9)

Not signed on (405)

405 members have not signed on to this bill.

Show all 405 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does SB 477 do?
relative to increasing transparency in the 340B Drug Pricing Program.
Who sponsors SB 477?
SB 477 is sponsored by Tim McGough (Republican), Julie Miles (Republican), Katelyn T Kuttab, Howard Pearl (Republican), Wayne MacDonald (Republican), Daniel Innis (Republican), Bill Gannon (Republican), Brian Cole (Republican), Regina Birdsell (Republican), and Keith Ammon (Republican).
What is the current status of SB 477?
This bill has been introduced in the Senate. Introduced November 21, 2025. It must pass committee before a floor vote.
Where can I track SB 477?
Track SB 477 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SB 477

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of SB 477

Last checked for changes about 2 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →